Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition.
Catella
F
F
Department of Medicine and Experimental Therapeutics, University College, Dublin, Ireland.
Reilly
M P
MP
Delanty
N
N
Lawson
J A
JA
Moran
N
N
Meagher
E
E
FitzGerald
G A
GA
D000082:Acetaminophen / Q000506:poisoning; D001241:Aspirin / Q000494:pharmacology*; D018592:Cross-Over Studies; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000378:metabolism / Q000652:urine; D004311:Double-Blind Method; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D010103:Oxygen Isotopes; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D012907:Smoking / Q000097:blood
D016861:Cyclooxygenase Inhibitors; D005229:Fatty Acids, Monounsaturated; D010103:Oxygen Isotopes; D010975:Platelet Aggregation Inhibitors; C075750:8-epi-prostaglandin F2alpha; D000082:Acetaminophen; D015237:Dinoprost; D001241:Aspirin; C054678:Satigrel